2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Tumor Treating Fields Therapy: new trials by email Literature Review of Tumor Treating Fields Therapy trials Research Report on Tumor Treating Fields Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer Questionnaire Administration, Tumor Treating Fields Therapy - Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma | Phase 2 | Terminated | OHSU Knight Cancer Institute | 3 | 2019-06-11 | 2023-10-30 |
| Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma Bevacizumab, TTFields Therapy - Glioblastoma, Glioma | Phase 2 | Terminated | RTOG Foundation, Inc. | 3 | 2017-05-09 | 2021-06-02 |
Glioblastoma (1) · Glioma (1) · Gliosarcoma (1) · Lung Neoplasms (1)
OHSU Knight Cancer Institute (1) · RTOG Foundation, Inc. (1)
United States (2)
Manmeet Ahluwalia, MD, FACP (1) · Timur Mitin, MD (1)